Britannia Life Sciences Inc's total assets for Q3 2024 were C$22.96M, a decrease of -3.80% from the previous quarter. TSE:BLAB total liabilities were C$11.06M for the fiscal quarter, a -4.54% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.